Chinese scientists and clinicians have developed a learning artificial intelligence system which can diagnose and identify cancerous prostate samples as accurately as any pathologist.
This holds out the possibility of streamlining and eliminating variation in the process of cancer diagnosis. It may also help overcome any local shortage of trained pathologists. In the longer term it may lead to automated or partially-automated prostate cancer diagnosis.
Prostate cancer is the most common male cancer, with around 1.1m diagnoses ever year, worldwide1 (for comparison, that’s around x4 the number of men who live in Copenhagen). Confirmation of the diagnosis normally requires a biopsy sample, which is then examined by a pathologist. Now an artificial intelligence learning system, presented at the European Association of Urology congress in Copenhagen, has shown similar levels of accuracy to a human pathologist. In addition, the software can accurately classify the level of malignancy of the cancer, so eliminating the variability which can creep into human diagnosis.
“This is not going to replace a human pathologist” said research leader Hongqian Guo (Nanjing, China), “We still need an experienced pathologist to take responsibility for the final diagnosis. What it will do is help pathologists make better, faster diagnosis, as well as eliminating the day-to-day variation in judgement which can creep into human evaluations”.
Prof. Guo’s group took 918 prostate whole mount pathology section samples from 283 patients, and ran these through the analysis system, with the software gradually learning and improving diagnosis. These pathology images were subdivided into 40,000 smaller samples; 30,000 of these samples were used to ‘train’ the software, the remaining 10,000 were used to test accuracy – the results showed an accurate diagnosis in 99.38% of cases (using a human pathologist as a ‘gold standard’), which is effectively as accurate as the human pathologist. They were also able to identify different Gleason Grades in the pathology sections using AI; ten whole mount prostate pathology sections have been tested so far, with similar Gleason Grade in the AI and human pathologist’s diagnosis. The group has not started testing the system with human patients.
Prof. Guo continued “The system was programmed to learn and gradually improve how it interpreted the samples. Our result show that the diagnosis the AI reported was at a level comparable to that of a pathologist. Furthermore, it could accurately classify the malignant levels of prostate cancer. Until now, automated systems have had limited clinical value, but we believe this is the first automated work to offer an accurate reporting and diagnosis of prostate cancer. In the short-term, this can offer a faster throughput, plus a greater consistency in cancer diagnosis from pathologist to pathologist, hospital to hospital, country to country.
Artificial intelligence is advancing at an amazing rate – you only need to look at facial recognition on smartphones, or driverless cars. It is important that cancer detection and diagnosis takes advantage of these changes”.
Commenting, Professor Rodolfo Montironi (Professor of Pathology, Polytechnic University of the Marche, Ancona, Italy) said:
“This is interesting work which shows how artificial intelligence will increasingly step into clinical practice. This may be very useful in some areas where there is a lack of trained pathologists. Like all automation, this will lead to a lesser reliance on human expertise, but we need to ensure that the final decisions on treatment stay with a trained pathologist. The really important thing though, is that we ensure the highest standard of patient care. The future will be interesting”. Professor Montironi was not involved in this work – this is an independent comment.
The Latest on: Artificial intelligence diagnostics
via Google News
The Latest on: Artificial intelligence diagnostics
Curetis: Novel Products and Study Data to be Presented at ECCMID 2018
on April 17, 2018 at 11:36 pm
Unyvero in vitro diagnostic (IVD) products are marketed in Europe ... with advanced bioinformatics and artificial intelligence. For further information, please visit www.curetis.com and www.ares-genetics.com. Legal Disclaimer This announcement contains ... […]
Artificial Intelligence in Health Care Market Detailed Study Analysis with Forecast by 2025
on April 16, 2018 at 10:46 pm
The outputs are used for real time decision support as well as long term planning. Artificial intelligence has various clinical applications such as oncology diagnostic assistance, medical image processing, physician and hospital error reduction ... […]
Agenda | Human Intelligence & Artificial Intelligence in Medicine Symposium | Stanford Medicine
on April 16, 2018 at 2:04 pm
10:10 AM Eric Topol Healthcare Ex Machina: How Artificial Intelligence Will Transform Medicine With ... Diagnosis - The Beauty and the Beast What are the cardinal features of diagnostic excellence? How good (or bad) are we now compared to what is possible? […]
New report: Global hospital artificial intelligence market research
on April 15, 2018 at 10:41 pm
Artificial intelligence is useful for providing highly tailored insights ... devices as all equipment and tools that are used either individually or together for diagnostics or therapy. This spectrum includes medical instruments, materials, devices ... […]
Artificial Intelligence: Are super smart killer robots going to take over the world?
on April 13, 2018 at 11:00 pm
For the first time, the US Food and Drug Administration has approved an artificial intelligence diagnostic device that doesn’t need a specialised doctor to interpret the results. The software program, called IDx-DR, can detect a form of eye disease by ... […]
Artificial intelligence may increase doctor productivity
on April 13, 2018 at 11:39 am
The system uses an autonomous AI diagnostic algorithm to immediately detect more ... PCON: What does the future of AI on the front line of health care look like? Abramoff: Artificial intelligence holds tremendous potential to lower costs, increase quality ... […]
Artificial intelligence in healthcare ‘set for 40% growth to 2024’
on April 13, 2018 at 2:53 am
The market for artificial intelligence in healthcare is poised for rapid growth ... pointing to studies suggesting AI can improve the diagnostic accuracy of CT scans, MRI scans and picture archiving and communications (PAC) by 60-70%. […]
First Artificial Intelligence (AI) Device Approved by US FDA for Diabetic Retinopathy
on April 12, 2018 at 9:27 pm
First Artificial Intelligence (AI)-based device to detect certain diabetes ... If a positive result is detected, patients should see an eye care provider for further diagnostic evaluation and possible treatment as soon as possible. The FDA evaluated ... […]
Coralville's IDx can sell its AI-based diagnostic system
on April 12, 2018 at 11:31 am
IDx’s diagnostic system is intended for use by primary care ... “Today’s decision permits the marketing of a novel artificial intelligence technology that can be used in a primary care doctor’s office,” said Malvina Eydelman, director of the ... […]
via Bing News